Peter Buhl Jensen
Amministratore Delegato presso CHOSA ONCOLOGY AB
Provenienza dei contatti di primo grado di Peter Buhl Jensen
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
University of Copenhagen
36
| College/University | Other Consumer Services | 36 |
Extinct | Pharmaceuticals: Major | 17 | |
12
| Public Company | Biotechnology | 12 |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
9
| Private Company | Pharmaceuticals: Major | 9 |
Allarity Therapeutics Europe ApS
Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Symbion A/S
Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark.
7
| Subsidiary | General Government | 7 |
Public Company | Miscellaneous Commercial Services | 6 | |
Medical Prognosis Institute, Inc.
2
| Subsidiary | 2 | |
Cobis A/S
Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Symbion Fonden
1
| Private Company | 1 | |
Buhl Krone Holding ApS
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Buhl Jensen tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Lund | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal | |
Technical University of Denmark | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
University of Aarhus | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Founder | |
University of Southern Denmark | College/University | Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Founder | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chairman | |
Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Chairman Corporate Officer/Principal Director/Board Member | |
ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member Director/Board Member | |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Oncology Venture US, Inc.
Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
Faculty of Engineering, Lund University | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
Copenhagen University Hospital | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Uppsala | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Camurus Lipid Research Foundation | Investment Trusts/Mutual Funds | Director/Board Member Chairman | |
XINTELA AB | Biotechnology | Director/Board Member Corporate Officer/Principal | |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Alfred Benzon Foundation | Director/Board Member Corporate Officer/Principal | ||
Lundbeck Foundation
Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member | |
The Carlsbergfondet Foundation
The Carlsbergfondet Foundation Financial ConglomeratesFinance Carlsbergfondet Foundation engages in the financing and promotion of art and art sciences. The company was founded by J. C. Jacobsen in 1876 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Confederation of Danish Industry
Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
COLOPLAST A/S | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer | |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Private Equity Investor | |
CAMURUS AB | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Healthcap III Sidefund GP AB | Investment Managers | Director/Board Member Director/Board Member | |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member Founder | |
Accelerace Management A/S
Accelerace Management A/S Investment ManagersFinance Accelerace Management A/S (Accelerace) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was established in 2008 and is owned by a group of institutional investors. | Investment Managers | Director/Board Member Private Equity Investor | |
WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Danimarca | 28 |
Svezia | 17 |
Stati Uniti | 5 |
Francia | 2 |
Regno Unito | 2 |
Settori
Health Technology | 24 |
Consumer Services | 10 |
Finance | 7 |
Miscellaneous | 4 |
Commercial Services | 4 |
Posizioni
Director/Board Member | 438 |
Corporate Officer/Principal | 215 |
Chairman | 160 |
Chief Executive Officer | 80 |
Independent Dir/Board Member | 75 |
Contatti più connessi
- Borsa valori
- Insiders
- Peter Buhl Jensen
- Connessioni Società